Your browser doesn't support javascript.
loading
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.
Felder, Mildred; Kapur, Arvinder; Gonzalez-Bosquet, Jesus; Horibata, Sachi; Heintz, Joseph; Albrecht, Ralph; Fass, Lucas; Kaur, Justanjyot; Hu, Kevin; Shojaei, Hadi; Whelan, Rebecca J; Patankar, Manish S.
Affiliation
  • Whelan RJ; Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, WI 53792, USA. rwhelan@oberlin.edu.
Mol Cancer ; 13: 129, 2014 May 29.
Article in En | MEDLINE | ID: mdl-24886523
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / CA-125 Antigen / Immunotherapy / Membrane Proteins / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / CA-125 Antigen / Immunotherapy / Membrane Proteins / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Reino Unido